Transcription of ICH HARMONISED TRIPARTITE GUIDELINE
{{id}} {{{paragraph}}}
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL. REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. ICH HARMONISED TRIPARTITE GUIDELINE . good MANUFACTURING PRACTICE GUIDE FOR. ACTIVE PHARMACEUTICAL INGREDIENTS. Q7. Current Step 4 version dated 10 November 2000. This GUIDELINE has been developed by the appropriate ICH Expert Working Group and has been subject to consultation by the regulatory parties, in accordance with the ICH Process. At Step 4 of the Process the final draft is recommended for adoption to the regulatory bodies of the European Union, Japan and USA. Q7. Document History New First Codification History Date Codification November 2005.
GOOD MANUFACTURING PRACTICE GUIDE FOR ACTIVE PHARMACEUTICAL INGREDIENTS ICH Harmonised Tripartite Guideline Having reached Step 4 of the ICH Process at the ICH Steering Committee meeting on 10 November 2000, this guideline is recommended for adoption to the three regulatory parties to ICH
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
GUIDELINE, Good Clinical Practice, Good, E6R2, GUIDELINES ON VALIDATION APPENDIX 5 VALIDATION OF, On good, World Health Organization, WAO guideline: management of urticaria, POP SMT Design Guideline, Guideline for the design & construction, GUIDELINE ORIGINAL ARTICLE GUIDELINE Adult, ORIGINAL ARTICLE GUIDELINE Adult antiretroviral therapy guidelines, Good Clinical Laboratory Practice